Combining siRNA Targeting HCV E2 Gene and Receptors to Fight Hepatitis C
Author Information
Author(s): Jahan Shah, Khaliq Saba, Samreen Baila, Ijaz Bushra, Khan Mahwish, Ahmad Waqar, Ashfaq Usman Alli, Hassan Sajida
Primary Institution: Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
Can combined siRNA targeting the HCV E2 gene and its cellular receptors effectively reduce HCV replication?
Conclusion
The study concludes that using combined RNAi to silence HCV E2 and its receptors significantly reduces HCV viral load.
Supporting Evidence
- siRNAs against HCV E2 and receptors significantly reduced viral load in treated cells.
- Combination treatment showed a greater reduction in HCV RNA compared to individual treatments.
- Western blot analysis confirmed decreased protein expression of HCV E2 and its receptors.
Takeaway
Scientists are trying to stop the hepatitis C virus by using tiny pieces of RNA to block the virus from entering cells. This method seems to work better when they target both the virus and the cell's helpers.
Methodology
The study used serum-infected Huh-7 cells and treated them with siRNAs targeting HCV E2 and cellular receptors, measuring viral load through Real Time PCR.
Limitations
The study may be limited by the in vitro nature of the experiments and the specific cell line used.
Participant Demographics
The study involved serum samples from local HCV-3a patients in Pakistan.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website